Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma
Bile duct cancer (cholangiocarcinoma) can be difficult to treat if standard surgery cannot remove the tumour. A liver transplant can offer a potential cure, but waiting for a donor organ takes time, during which the cancer might grow or spread. This NHS study, called EMPHATIC, tests a combination of intensive treatments to keep the cancer in check while patients wait for a transplant. Patients receive chemotherapy alongside proton beam therapy. Proton beam therapy is an advanced, highly targeted form of radiation that attacks cancer cells while sparing nearby healthy organs. The trial is open to eligible UK patients aged 17 and over who are fit enough for major surgery and meet specific criteria. All participants receive proton therapy at specialist NHS centres in Manchester or London, with accommodation provided if needed. Doctors hope this approach will offer a cure for people who previously had limited options.
At a glance
What is this study about?
Bile duct cancer develops in the small tubes that carry digestive fluid from the liver to the gut. The usual treatment is surgery to cut out the tumour, but for many people, the cancer is positioned in a way that makes it impossible to remove safely. In these cases, replacing the whole liver with a donor liver (a liver transplant) can offer a chance of a cure. However, waiting lists for a donor liver can be long, and there is a high risk that the cancer could grow or spread while waiting, meaning a transplant would no longer be safe or effective.
The EMPHATIC study is testing a plan to protect patients while they wait for a donor liver. Patients are given chemotherapy drugs alongside proton beam therapy. Unlike traditional radiotherapy, which uses X-ray beams that pass straight through the body, proton beams stop exactly where the tumour is. This allows doctors to deliver a powerful dose of radiation directly to the cancer while causing far less damage to the surrounding healthy liver, stomach, and bowel.
This trial is part of an NHS programme evaluating how best to use proton beam therapy across the UK. Because this is not a randomised trial, every eligible person who joins will receive the proton treatment. By controlling the cancer with chemotherapy and targeted radiation, researchers hope more patients can safely reach their transplant surgery and go on to live cancer-free.
Key takeaways
- The EMPHATIC study offers a potential cure for bile duct cancer that cannot be removed with ordinary surgery.
- It combines targeted proton beam therapy, chemotherapy, and a liver transplant.
- Proton beams target the tumour directly, causing less damage to healthy parts of your body.
- All eligible participants receive the treatment; nobody is given a placebo.
- Treatment takes place at NHS specialist centres in London or Manchester, with accommodation provided.
Who may be eligible?
This study is designed for people aged 17 and older who have been diagnosed with bile duct cancer that cannot be taken out with ordinary surgery. At the start of the study, patients must also have a history of primary sclerosing cholangitis (PSC), an inflammatory condition of the bile ducts, though criteria may widen later. Your tumour must be smaller than 3 centimetres across, and you must be generally active and well enough to cope with chemotherapy and major transplant surgery.
You will not be able to join if the cancer has spread to your lymph nodes or other parts of your body outside the liver. You also cannot take part if you have had radiation therapy to your upper tummy area in the past, have severe kidney disease, have an active, uncontrolled infection, or have been treated for another serious cancer within the last five years.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you aged 17 or over?
- Have you been diagnosed with bile duct cancer that cannot be removed by standard surgery?
- Is your tumour smaller than 3 centimetres across?
- Has your medical team confirmed the cancer has not spread outside your liver?
- Do you have a background of primary sclerosing cholangitis (PSC)?
- Are you generally mobile, independent, and well enough for major surgery?
What does participation involve?
If you take part, your care will be coordinated between your local hospital and one of the UK's specialist NHS proton centres in London or Manchester. You will first have tests, including scans and blood tests, to make sure you are fit for treatment. You will receive chemotherapy, which involves both drips into a vein and tablets taken at home. You will also travel to London or Manchester for daily proton beam therapy sessions over several weeks. If you live far away, free accommodation is provided for you and a companion.
After finishing your chemotherapy and proton beam therapy, you will be placed on the liver transplant waiting list. During this time, your healthcare team will monitor you closely with regular scans. Once a matching donor liver becomes available, you will have your transplant surgery. Following your operation, you will have routine clinic visits, blood tests, and scans for several years so doctors can support your recovery and check that the cancer has not returned.
Potential risks and benefits
Locations (2)
- University College London Hospitals NHS Foundation TrustVerified postcodeLondon, United Kingdom· Recruiting
- The Christie NHS Foundation TrustVerified postcodeManchester, United Kingdom· Recruiting
Common questions
Will I have to pay for proton beam therapy or travel accommodation?
No. The treatment is fully funded by the NHS. If you need to travel to London or Manchester for proton therapy, accommodation is provided for you and a carer or family member.
Is this a randomised trial where I might get a dummy treatment?
No. There are no placebos (dummy treatments) in this study. Every patient who is eligible and agrees to join will receive the active chemotherapy, proton beam therapy, and be put forward for a transplant.
What is primary sclerosing cholangitis (PSC)?
PSC is a long-term condition where the bile ducts inside and outside the liver become inflamed and scarred. People with PSC have a higher risk of developing bile duct cancer.
What happens if a donor liver does not become available quickly?
The chemotherapy and proton beam therapy are specifically designed to shrink and control the cancer for as long as possible, keeping you stable while you wait on the transplant list.
Can I leave the study if I change my mind?
Yes. You are free to stop participating at any point. Your medical team will simply discuss alternative treatment options with you, and your standard NHS rights and care will not be harmed.
How to find out more
Romelie Rieu
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.